Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost insurers ask you to declare any prescription medicine or pre-existing condition before you travel. To add Mounjaro to travel insurance, contact your provider before your trip, disclose that you take tirzepatide as a prescribed weight-management medicine, and ask specifically whether the condition it treats is included in your medical screening. Failing to declare a prescription medicine can invalidate a claim, so this step is worth a phone call — not a footnote. Mounjaro (tirzepatide) is a prescription-only medicine available in the UK for weight management, and your insurer needs to know it exists in your bag before you board.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people starting Mounjaro assume that because it's used for weight management, rather than something more obviously "medical" like insulin or blood thinners, they don't need to mention it to their insurer. That assumption is worth letting go of gently, because it isn't how travel insurance underwriting works.
Mounjaro (tirzepatide) is a Prescription-Only Medicine regulated by the MHRA. The fact that it requires a prescriber's assessment and a valid prescription places it firmly in the category of medicines most travel insurers require you to disclose. Beyond the medicine itself, the underlying condition being treated, whether that is obesity, type 2 diabetes, or a related condition such as hypertension or dyslipidaemia, is usually what the insurer's medical screening questionnaire is really asking about. You can read more about Mounjaro and how it works if you want a clear picture of what your insurer will be looking at.
Declaring openly is always the safer course. Non-disclosure, even unintentional, can give an insurer grounds to reject a claim that would otherwise have been paid.
Contact your travel insurer directly before purchasing or activating a policy, ideally before booking your trip. Most UK providers have a medical screening line or an online questionnaire. When you reach it, you need to declare two things: the medicine (tirzepatide, brand name Mounjaro) and the condition or conditions for which it was prescribed.
Ask explicitly whether your cover includes medical emergencies related to your weight-management condition and any associated health issues. Ask whether prescription medicines are covered if lost, stolen or damaged in transit. Some policies cover replacement medicine costs abroad; many do not without an endorsement. It is also sensible to ask about medical equipment, since cold storage for your pen may be relevant on a long-haul flight or a warm-climate trip.
The question of whether to declare Mounjaro comes up regularly, and the answer is consistent: yes, and sooner rather than later. Keep a record of the call or online screening reference number.
Declaring to your insurer is one step. Travelling with the pens safely is another. Mounjaro pens must be kept refrigerated at 2–8°C. Airlines generally allow insulin and other temperature-sensitive medicines in cabin baggage, and tirzepatide is in the same category; a letter from your prescriber confirming the medicine is prescribed to you by name is advisable for airport security and, in some countries, customs.
For the flight itself, an insulated cool bag or a small medical travel cooler keeps the pen within range. Check the patient information leaflet for the short window during which a pen can be kept at room temperature, and plan your journey accordingly. Once you land, ask your hotel in advance about fridge access, most will accommodate a medical request without issue.
If you need spare needles or alcohol swabs for injection-site cleaning during a longer trip, stock up before you travel; medical-grade swabs are straightforward to order in the UK. Carrying a waste-safe option for used needles matters too, particularly if you are in a country with limited disposal infrastructure.
The Mounjaro injection guide has practical detail on pen handling that is useful context when you are planning around travel days.
Some people land on this page before they have even begun treatment. If that's you, the process at a regulated private pharmacy is straightforward: a free consultation, reviewed the same working day by a real prescriber rather than automated software, followed by next-working-day delivery once approved. For guidance on what the treatment involves and whether it is clinically suitable for you, the treatment consultation page covers eligibility and next steps.
For broader context on Mounjaro and travel insurance considerations, including how different insurers approach the declaration, that page goes into further detail on the policy landscape. The effect Mounjaro has on existing policies is a related question worth reading before you renew.
NHS England's guidance on weight-management injections covers practical considerations for people taking these medicines, including advice on storage and what to discuss with your clinical team before travel. The NHS England weight-management injections page is a reliable starting point for official UK guidance. For the full prescribing information and storage instructions that an insurer may ask you to reference, the Mounjaro SmPC on the eMC is the authoritative document. If you are also considering or currently using Zepbound, another tirzepatide injection, the same disclosure and storage principles apply when travelling.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.